An Introduction to FDA MyStudies: An Open-Source, Digital Platform to Gather Real World Data for Clinical Trials and Research Studies – May 9, 2019
10:00 a.m. – 3 p.m. Eastern
This on-demand webinar is FREE. Recordings are below.
ABOUT THIS EVENT
The FDA released code and technical documentation for the FDA MyStudies Platform on November 20, 2018. External organizations can now use these materials to configure and create branded apps for their own use in traditional clinical trials as well as real world evidence studies and registries.
This event will demonstrate the capabilities of the system as well as its associated web-based configuration portal and data storage environment. Developers will receive an orientation to the GitHub repository and will learn helpful tips for setting up and configuring the system for study managers and participants.
Session One: Introduction to FDA MyStudies Mobile App System
Session Two: A Demonstration of the FDA MyStudies Mobile App System: Patient and Researcher Experiences
On-Demand Webinar Part I with Zachary Wyner from Harvard Medical School & Harvard Pilgrim Health Care Institute
Audio Recording Part I
On-Demand Webinar Part II with Zachary Wyner
Audio Recording Part II
Questions and Answers
Session Three: Mobile Application and WCP: Usability and Technical Overview
Session Four: Response Server Technical Overview
Session Five: Deploying the MyStudies System in a Compliant Manner
Questions and Answers and Closing Remarks
- Professionals involved in Clinical Research, Post Market Studies, Regulatory Affairs, Medical Affairs, Real World Evidence, Health Economics and Outcomes Research, and Population Health Management
- Application developers and Secure Data Storage and Analytics Solutions developers working in the health care space
- Foreign regulators
- Hear directly from FDA subject matter experts on the use of digital tools such as the FDA MyStudies platform to gather real-world data for research and help inform regulatory decision-making.
- Understand the capabilities of the mobile apps built on iOS ResearchKit and Android ResearchStack frameworks, respectively.
- Learn how the code base of these apps is designed to make them ‘framework apps’ and can be replicated for any number of studies, with minimal coding effort, to set up new apps for new studies.
- Observe in real-time how study content can be created, published, and managed using the web-based Configuration Portal. See how those changes are reflected dynamically in the mobile apps and the Response Server.
- Take a deep dive into the capabilities and architecture of the Response Server to understand how responses are processed and stored. Learn about the many options provided for retrieving and analyzing these data, including linking responses to patient records.
- Identify features of the MyStudies platform intended to enhance usability and user experience.
- Understand the conceptual architecture of the MyStudies platform including use of iOS ResearchKit and Android ResearchStack in order to facilitate future private and public sector development.
- Take a guided virtual tour of the major components of the MyStudies GitHub repository and ask questions of subject matter experts from Boston Technology Corporation and LabKey who developed the platform applications.
- Learn how the MyStudies server components can be deployed in a FISMA- and HIPAA-compliant cloud hosting environment. Review key deployment decisions made and best practices used in hosting multiple studies using this system.
- FDA’s MyStudies Application (App)
- Framework for FDA's Real-World Evidence Program
- Guidance for Industry Part 11, Electronic Records; Electronic Signatures — Scope and Application
- Real World Evidence - FDA webpage
- Webinar: Framework for FDA’s Real-World Evidence Program – Mar 15, 2019
- FDA In Brief: FDA launches new digital tool to help capture real world data from patients to help inform regulatory decision-making
- FDA’s MyStudies Application (App)
- GitHub FDA MyStudies Mobile Application System
- FDA GUIDANCE DOCUMENT - Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers Guidance for Institutional Review Boards, Investigators, and Sponsors December 2016
- GUIDANCE DOCUMENT - Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11 – June 2017
- GUIDANCE DOCUMENT - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims - Guidance for Industry - December 2009
- Real World Evidence
- GitHub Repository: Response Server Module
- Subversion Repository: LabKey Server Platform
- Documentation and Support for Building & Deploying LabKey Server
- This five-hour webinar is RAPS eligible for credit towards a participant’s RAC recertification upon full completion.
- SOCRA accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area.
- This event is SQA approved for 0.25 non-GCP or non-GLP units per 1 hour towards RQAP re-registration
- ACRP provides continuing medical education for the completion of this educational activity. Contact hours are provided at 1 unit for at least 45 minutes of qualified material.
- Attendance certificates are only available during the two weeks after the event. Attendance is required.
For questions concerning the webinar, please contact CDER SBIA at: CDERSBIA@fda.hhs.gov or call (866) 405-5367 | (301) 796-6707
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.